ponatinib 15 mg
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ponatinib 15 mg, covering 2019-08-02 to 2019-08-02. Get the full timeline:
Most recent: Clinical Trial Update: Consolidation Treatment With Ponatinib 15 mg on Treatment Free-Remission Rate in Patients With Chronic Myeloid Leukemia [Phase 2]